东方生物
(688298)
| 流通市值：59.59亿 | | | 总市值：59.59亿 |
| 流通股本：2.02亿 | | | 总股本：2.02亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,461,879,336.55 | 4,164,735,978.75 | 4,879,469,153.29 | 5,496,264,243.18 |
| 应收票据及应收账款 | 223,266,588.45 | 207,736,254.65 | 246,839,672.98 | 275,229,157.19 |
| 其中：应收票据 | 1,917,744.25 | 1,573,180 | - | - |
| 应收账款 | 221,348,844.2 | 206,163,074.65 | 246,839,672.98 | 275,229,157.19 |
| 预付款项 | 40,486,982.81 | 28,607,903.43 | 49,069,594.63 | 46,229,023.05 |
| 其他应收款合计 | 30,027,866.84 | 20,701,287.53 | 81,234,824.17 | 90,598,582.36 |
| 存货 | 384,971,322.46 | 346,775,187.97 | 429,538,632.32 | 414,320,414.6 |
| 其他流动资产 | 92,898,828.97 | 75,401,614.1 | 160,449,034.62 | 147,081,045.53 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 5,271,199,464.93 | 5,896,256,738.14 | 6,702,004,059.7 | 7,323,188,068.49 |
| 非流动资产: | | | | |
| 长期股权投资 | 20,374,348.06 | 21,235,457.08 | 19,725,328.51 | 20,580,043.78 |
| 其他非流动金融资产 | 30,998,302.68 | 31,114,730.78 | 28,866,871.97 | 29,314,988.87 |
| 固定资产 | 1,413,313,631.8 | 1,408,476,667.38 | 898,673,916.67 | 908,098,979.21 |
| 在建工程 | 830,138,237.32 | 796,483,365.12 | 651,851,731 | 533,217,684.2 |
| 使用权资产 | 79,598,579.35 | 56,211,004.41 | 24,375,104.15 | 31,868,617.12 |
| 无形资产 | 481,750,208.54 | 478,814,433.79 | 510,557,855.24 | 526,070,439.08 |
| 商誉 | 45,625,034.22 | - | - | - |
| 长期待摊费用 | 58,243,446.75 | 61,050,149.04 | 43,667,757.46 | 46,916,961.07 |
| 递延所得税资产 | 227,361,997.93 | 218,256,291.09 | 177,997,886.23 | 183,990,366.68 |
| 其他非流动资产 | 300,750,937.85 | 28,052,313.91 | 112,265,214.56 | 108,210,274.3 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 3,488,154,724.5 | 3,099,694,412.6 | 2,467,981,665.79 | 2,388,268,354.31 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,759,354,189.43 | 8,995,951,150.74 | 9,169,985,725.49 | 9,711,456,422.8 |
| 流动负债: | | | | |
| 短期借款 | 176,773,891.67 | 198,221,896.67 | 201,000,000 | 200,000,000 |
| 交易性金融负债 | - | 15,830,213.93 | - | - |
| 应付票据及应付账款 | 363,836,178.25 | 600,485,929.48 | 478,604,228.01 | 871,784,564.34 |
| 其中：应付票据 | 13,538,724.13 | 25,760,319.32 | 120,551,449.09 | 446,020,914.67 |
| 应付账款 | 350,297,454.12 | 574,725,610.16 | 358,052,778.92 | 425,763,649.67 |
| 合同负债 | 33,966,055.34 | 34,768,741.84 | 30,633,353.53 | 34,934,824.66 |
| 应付职工薪酬 | 34,311,006.37 | 61,156,537.24 | 32,022,038.19 | 30,230,542.49 |
| 应交税费 | 3,464,472.24 | 11,579,674.96 | 4,445,127.41 | 9,654,964.55 |
| 其他应付款合计 | 156,636,231.76 | 96,341,168.22 | 94,582,199.89 | 103,193,590.9 |
| 一年内到期的非流动负债 | 374,439,141.33 | 66,156,620.82 | 4,671,568.15 | 5,626,415.34 |
| 其他流动负债 | 1,897,321.26 | 1,246,500.81 | 1,888,335.52 | 1,689,329.32 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,145,324,298.22 | 1,085,787,283.97 | 847,846,850.7 | 1,257,114,231.6 |
| 非流动负债: | | | | |
| 长期借款 | - | 300,000,000 | 350,000,000 | 350,000,000 |
| 租赁负债 | 61,003,718.5 | 43,955,287.29 | 23,954,969.33 | 25,286,750.93 |
| 长期应付款 | - | - | 4,000,000 | 4,660,000 |
| 预计负债 | 5,670,252 | 5,695,893 | - | - |
| 递延收益 | 10,535,754.89 | 10,748,513.56 | 14,383,489.83 | 14,545,118.07 |
| 递延所得税负债 | - | 36,024.89 | 2,753,443.36 | 2,753,443.36 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 77,209,725.39 | 360,435,718.74 | 395,091,902.52 | 397,245,312.36 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,222,534,023.61 | 1,446,223,002.71 | 1,242,938,753.22 | 1,654,359,543.96 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 201,600,000 | 201,600,000 | 201,600,000 | 201,600,000 |
| 资本公积 | 395,773,417.88 | 395,423,568.68 | 403,177,585.86 | 403,177,585.86 |
| 其他综合收益 | 34,021,350.37 | 42,374,252.48 | 53,145,262.45 | 57,186,910.47 |
| 盈余公积 | 84,000,000 | 84,000,000 | 84,000,000 | 84,000,000 |
| 未分配利润 | 6,645,320,084.79 | 6,712,673,580.19 | 7,037,873,194.73 | 7,145,064,761.95 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,360,714,853.04 | 7,436,071,401.35 | 7,779,796,043.04 | 7,891,029,258.28 |
| 少数股东权益 | 176,105,312.78 | 113,656,746.68 | 147,250,929.23 | 166,067,620.56 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,536,820,165.82 | 7,549,728,148.03 | 7,927,046,972.27 | 8,057,096,878.84 |
| 负债和股东权益合计 | 8,759,354,189.43 | 8,995,951,150.74 | 9,169,985,725.49 | 9,711,456,422.8 |
| 公告日期 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |